PELUCCHI, SILVIA CECILIA
PELUCCHI, SILVIA CECILIA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer's disease and correlates with tau pathology
2025 A. Padovani, A. Pilotto, S. Pelucchi, L. D'Andrea, R. Stringhi, F. Gorla, B. Aksan, S. Caratozzolo, A. Benussi, A. Galli, C. Tirloni, D. Mauceri, A. Canale, S. Archetti, B. Borroni, M. Di Luca, E. Marcello
Nonlinear mixed-effects models to analyze actin dynamics in dendritic spines
2025 G. Di Credico, S. Pelucchi, F. Pauli, R. Stringhi, E. Marcello, V. Edefonti
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
2025 S. Pelucchi, L.D. Dalt, G.D. Cesare, R. Stringhi, L. D'Andrea, F.L. Greca, C. Cambria, L. Vandermeulen, E. Zianni, S. Musardo, S. Roda, F. Bonacina, S. Nasini, M.G. Lupo, N. Ferri, S. Comai, F. Gardoni, F. Antonucci, D. Scheggia, M.D. Luca, G.D. Norata, E. Marcello
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features
2024 M. Italia, M. Salvadè, F. La Greca, E. Zianni, S. Pelucchi, A. Spinola, E. Ferrari, S. Archetti, A. Alberici, A. Benussi, E. Solje, A. Haapasalo, D. Hoffmann, K. Katisko, J. Krüger, R. Facchinetti, C. Scuderi, A. Padovani, M. Diluca, D. Scheggia, B. Borroni, F. Gardoni
Glucose-derived glutamate drives neuronal terminal differentiation in vitro
2024 L. D'Andrea, M. Audano, S. Pedretti, S. Pelucchi, R. Stringhi, G. Imperato, G. De Cesare, C. Cambria, M.H. Laporte, N. Zamboni, F. Antonucci, M. Di Luca, N. Mitro, E. Marcello
An association study of cyclase-associated protein 2 and frailty
2023 S. Pelucchi, C. Macchi, L. D'Andrea, P.D. Rossi, M.C. Speciani, R. Stringhi, M. Ruscica, B. Arosio, M. Di Luca, M. Cesari, V. Edefonti, E. Marcello
Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy
2023 C.M. Castillo Bautista, K. Eismann, M. Gentzel, S. Pelucchi, J. Mertens, H.E. Walters, M.H. Yun, J. Sterneckert
Novel therapeutic approaches to target neurodegeneration
2023 A.G. de la Fuente, S.C. Pelucchi, J. Mertens, M.M.G. Diluca, D. Mauceri, E. Marcello
Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer’s disease
2022 L. Traxler, J.R. Herdy, D. Stefanoni, S. Eichhorner, S. Pelucchi, A. Szücs, A. Santagostino, Y. Kim, R.K. Agarwal, J.C.M. Schlachetzki, C.K. Glass, J. Lagerwall, D. Galasko, F.H. Gage, A. D’Alessandro, J. Mertens
The epilepsy-associated protein PCDH19 undergoes NMDA receptor-dependent proteolytic cleavage and regulates the expression of immediate-early genes
2022 L. Gerosa, S. Mazzoleni, F. Rusconi, A. Longaretti, E. Lewerissa, S. Pelucchi, L. Murru, S.G. Giannelli, V. Broccoli, E. Marcello, N.N. Kasri, E. Battaglioli, M. Passafaro, S. Bassani
Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion
2022 L. Böhnke, L. Zhou-Yang, S. Pelucchi, F. Kogler, D. Frantal, F. Schön, S. Lagerström, O. Borgogno, J. Baltazar, J.R. Herdy, S. Kittel-Schneider, M. Defrancesco, J. Mertens
Synaptic dysfunction in early phases of Alzheimer's Disease
2022 S. Pelucchi, F. Gardoni, M. Di Luca, E. Marcello
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients
2022 A.D. Maio, A. De Rosa, S. Pelucchi, M. Garofalo, B. Marciano, T. Nuzzo, F. Gardoni, A.M. Isidori, M. Di Luca, F. Errico, A. De Bartolomeis, E. Marcello, A. Usiello
Neck dissection and trans oral robotic surgery for oropharyngeal squamous cell carcinoma
2022 G. Meccariello, A. Maniaci, G. Bianchi, G. Cammaroto, G. Iannella, A. Catalano, R. Sgarzani, A. De Vito, P. Capaccio, S. Pelucchi, C. Vicini
ATM rules neurodevelopment and glutamatergic transmission in the hippocampus but not in the cortex
2022 E. Focchi, C.M. Cambria, L. Pizzamiglio, L. Murru, S.C. Pelucchi, L. D'Andrea, S. Piazza, L. Mattioni, M. Passafaro, E. Marcello, G. Provenzano, F. Antonucci
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease
2022 S. Musardo, S. Therin, S. Pelucchi, L. D'Andrea, R. Stringhi, A. Ribeiro, A. Manca, C. Balducci, J. Pagano, C. Sala, C. Verpelli, V. Grieco, V. Edefonti, G. Forloni, F. Gardoni, G. Meli, D. Di Marino, M. Di Luca, E. Marcello
Peptidi inibitori dell'endocitosi di ADAM10 e relativi usi nel trattamento della malattia di Alzheimer
2021 E. Marcello, M. Di Luca, S. Pelucchi, L. Vandermeulen, F. Gardoni, D. Di Marino
Transcranial magnetic stimulation exerts “rejuvenation” effects on corticostriatal synapses after partial dopamine depletion
2021 G. Natale, A. Pignataro, G. Marino, F. Campanelli, V. Calabrese, A. Cardinale, S. Pelucchi, E. Marcello, F. Gardoni, M.T. Viscomi, B. Picconi, M. Ammassari-Teule, P. Calabresi, V. Ghiglieri
Adam10 plasma and csf levels are increased in mild Alzheimer’s disease
2021 I.P. Vanatabe, R. Peron, M.M. Grigoli, S. Pelucchi, G. De Cesare, T. Magalhaes, P.R. Manzine, M.L.F. Balthazar, M. Di Luca, E. Marcello, M.R. Cominetti
Dendritic spines in alzheimer’s disease : How the actin cytoskeleton contributes to synaptic failure
2020 S. Pelucchi, R. Stringhi, E. Marcello